Did You Know?

Editor’s Picks

Latest News

Amphista Therapeutics announces new AMX-883 data to be presented at the ASH Annual Meeting and Exposition and provides a business progress update

AMX-883 shows synergistic efficacy in combination with venetoclax in vivo and prevents the emergence of resistance to venetoclax in vitro, addressing...

If your personal information was accessed during the September 2024 data security incident that impacted American Association of Colleges of Osteopathic Medicine (AACOM), a proposed class action Settlement may affect your rights

error: Content is protected !!